+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peptide API CDMO Services Market - Global Forecast 2026-2032- Product Image
Peptide API CDMO Services Market - Global Forecast 2026-2032- Product Image
Sale

Peptide API CDMO Services Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6090485
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Peptide API CDMO Services Market is projected to reach USD 3.53 Billion in 2026. It is expected to continue growing at a CAGR of 11.88%, reaching USD 6.91 Billion by 2032.

Peptide API CDMO Services: Executive Overview

Peptide API contract development and manufacturing services support pharmaceutical and biotechnology developers with process development, analytical testing, scale-up, regulatory documentation, and commercial production of peptide active pharmaceutical ingredients (APIs). Demand is shaped by the expansion of peptide-based medicines, increasingly complex molecular designs, stringent quality expectations, and the need for specialized manufacturing infrastructure. The competitive context is defined by technical capability, compliance, capacity flexibility, supply assurance, and the ability to manage development programs from laboratory scale through validated production.

Manufacturing Complexity Is Reshaping Peptide API Outsourcing

The landscape is shifting from basic synthesis support toward integrated, lifecycle-oriented services. Longer and more complex peptide sequences, constrained structures, conjugated molecules, highly potent compounds, and specialized purification requirements are increasing the importance of process control and analytical depth. Manufacturers are also adapting to tighter expectations for impurity characterization, cleaning validation, data integrity, serialization, environmental management, and continuity planning. Developers increasingly value partners that can coordinate chemistry, quality, regulatory, formulation-related interfaces, and technology transfer across multiple stages rather than provide isolated production tasks.

Artificial Intelligence Is Improving Development Decisions and Operational Control

Artificial intelligence is being applied to peptide design, sequence evaluation, route selection, process optimization, impurity prediction, analytical method development, and manufacturing monitoring. Machine-learning tools can help prioritize experiments, identify process variables, detect deviations, and support predictive maintenance, although their effectiveness depends on representative data, validated workflows, and expert oversight. In regulated environments, explainability, auditability, cybersecurity, model governance, and documented human review remain essential. The most practical near-term value lies in augmenting scientists and operations teams while preserving established quality systems and regulatory accountability.

Regional Insights: Specialized Capacity and Regulatory Alignment Drive Differentiation

North America combines strong pharmaceutical development activity with demanding regulatory and quality expectations, encouraging investment in advanced peptide process development and reliable domestic or regional supply. Europe emphasizes quality systems, environmental performance, technology transfer, and cross-border regulatory coordination across mature manufacturing networks. Asia-Pacific benefits from extensive chemical and pharmaceutical manufacturing expertise, growing innovation ecosystems, and expanding development capabilities, while customers continue to assess quality consistency, intellectual-property protection, and supply resilience. Latin America is developing outsourcing relationships around access, localization, and partnerships with established producers. The Middle East is prioritizing life-sciences diversification and supply security, while Africa remains focused on strengthening pharmaceutical manufacturing ecosystems, technical skills, and dependable access to specialized inputs.

Group Insights: Trade, Regulation, and Supply Resilience Shape Engagement

ASEAN presents opportunities for regional manufacturing integration and pharmaceutical supply-chain development, with regulatory harmonization and technical capability varying among member states. BRICS markets combine substantial pharmaceutical demand and industrial capacity with differing approval systems, infrastructure, and investment conditions, making local partnerships and compliance expertise important. The European Union benefits from coordinated regulatory structures and advanced quality expectations, while the G7 places strong emphasis on innovation, traceability, resilience, and rigorous oversight. GCC countries are supporting healthcare and industrial diversification, creating interest in technology transfer and dependable supply. NATO members collectively reflect heightened attention to critical supply chains, strategic resilience, and continuity planning, although peptide API procurement remains primarily governed by healthcare and pharmaceutical requirements.

Country Insights: Capabilities, Demand, and Compliance Priorities Differ

The United States combines advanced drug development with stringent quality and regulatory expectations, while Canada contributes research strength and cross-border pharmaceutical integration. Germany, France, Italy, Spain, and the United Kingdom offer sophisticated life-sciences ecosystems, established regulatory expertise, and demand for reliable, high-quality outsourcing. China and India provide substantial chemical and pharmaceutical manufacturing capabilities, supported by expanding peptide expertise and domestic demand; customers commonly evaluate validation depth, documentation, intellectual-property safeguards, and continuity controls. Japan and South Korea emphasize precision manufacturing, quality assurance, and advanced pharmaceutical innovation. Australia supports research-led development and regional collaboration. Brazil and Mexico are important Latin American pharmaceutical markets where access, localization, regulatory navigation, and dependable import or regional supply arrangements influence outsourcing decisions. Russia’s operating environment is shaped by regulatory, trade, and access considerations, requiring careful assessment of applicable compliance and supply-chain conditions.

Action Priorities for Leaders in Peptide API Outsourcing

Industry leaders should qualify partners against the full development-to-commercial pathway, including sequence-specific chemistry, impurity control, analytical validation, containment, quality systems, and technology-transfer readiness. They should establish dual-source or contingency strategies for critical raw materials, specialist equipment, and high-risk process steps, while using clear governance for change control and deviation management. Investments in automation and artificial intelligence should be tied to validated use cases, secure data architecture, and measurable improvements in cycle time, right-first-time performance, or investigation quality. Regional partner selection should account for regulatory compatibility, intellectual-property protection, environmental controls, workforce depth, logistics, and business continuity. Early technical due diligence and transparent communication with regulators can reduce avoidable delays as programs advance.

Research Methodology: Evidence-Based Assessment of Peptide API CDMO Services

This executive summary uses a structured assessment of the peptide API CDMO services value chain, covering demand drivers, technical requirements, regulatory conditions, manufacturing capabilities, supply-chain considerations, and adoption of digital tools. Insights are synthesized from publicly available regulatory frameworks, pharmaceutical development practices, manufacturing and quality-system principles, regional industrial conditions, and established trends in peptide chemistry and outsourcing. Regional, group, and country comparisons focus on observable differences in infrastructure, policy, innovation, compliance, workforce, and supply resilience. The analysis excludes market estimates, market sizing, market shares, forecasts, and unverified claims, and treats artificial intelligence as an enabling technology whose impact depends on validation and governance.

Conclusion: Resilience and Technical Depth Will Define Peptide API Partnerships

Peptide API CDMO services are becoming more technically demanding as developers pursue complex molecules and higher expectations for quality, speed, traceability, and supply assurance. Success will depend less on basic production availability and more on integrated process knowledge, analytical rigor, regulatory readiness, flexible capacity, and robust continuity planning. Artificial intelligence can strengthen these capabilities when deployed within validated systems and supported by expert judgment. Leaders that build transparent, resilient, and technically aligned partnerships will be better positioned to advance peptide programs while managing quality, compliance, and operational risk.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Peptide API CDMO Services Market, by Type
7.1. Introduction
7.2. Analytical Testing & Quality Control Services
7.3. Manufacturing Services
7.4. Packaging & Labeling Services
7.5. Peptide Synthesis Services
7.6. Process Development & Optimization
8. Peptide API CDMO Services Market, by Category
8.1. Introduction
8.2. GMP Services
8.3. Non-GMP Services
9. Peptide API CDMO Services Market, by Manufacturing Process
9.1. Introduction
9.2. Liquid Phase Synthesis
9.3. Solid Phase Synthesis
10. Peptide API CDMO Services Market, by Application
10.1. Introduction
10.2. Biochemistry
10.3. Immunology
10.4. Medicine
10.5. Molecular Biology
11. Peptide API CDMO Services Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Biotechnology Firms
11.4. Contract Research Organizations
11.5. Pharmaceutical Companies
11.6. Research and Development (R&D) Laboratories
12. Peptide API CDMO Services Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Peptide API CDMO Services Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Peptide API CDMO Services Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Advanced Peptide Technologies Ltd.
16.2. Almac Group
16.3. AmbioPharm Inc.
16.4. Asymchem Inc.
16.5. Axplora Group GmbH
16.6. Bachem Holding AG
16.7. Cambrex Corporation
16.8. Corden Pharma International GmbH
16.9. CordenPharma GmbH
16.10. CPC Scientific Inc.
16.11. EUROAPI UK Ltd
16.12. Evonik Industries AG
16.13. Genscript Biotech Corporation
16.14. Lonza Group AG
16.15. Merck KGaA
16.16. Neuland Laboratories Ltd.
16.17. PCI Pharma Services
16.18. Piramal Pharma Limited
16.19. Polypeptide Group
16.20. Siegfried Holding AG
16.21. Syngene International Ltd.
16.22. Thermo Fisher Scientific Inc.
16.23. WuXi AppTec Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Peptide API CDMO Services Market, Years Considered for the Study
FIGURE 2. Global Peptide API CDMO Services Market, Research Design
FIGURE 3. Global Peptide API CDMO Services Market, Research Framework
FIGURE 4. Global Peptide API CDMO Services Market, Data Triangulation
FIGURE 5. Global Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Peptide API CDMO Services Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Peptide API CDMO Services Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Peptide API CDMO Services Market Size, by Category, 2025 vs 2032 (%)
FIGURE 9. Global Peptide API CDMO Services Market Size, by Category, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Peptide API CDMO Services Market Size, by Manufacturing Process, 2025 vs 2032 (%)
FIGURE 11. Global Peptide API CDMO Services Market Size, by Manufacturing Process, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Peptide API CDMO Services Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Peptide API CDMO Services Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Peptide API CDMO Services Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Peptide API CDMO Services Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Peptide API CDMO Services Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Peptide API CDMO Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Peptide API CDMO Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Peptide API CDMO Services Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Peptide API CDMO Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Peptide API CDMO Services Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Peptide API CDMO Services Market Segmentation & Coverage
TABLE 2. Global Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 3. Global Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global Analytical Testing & Quality Control Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Analytical Testing & Quality Control Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Analytical Testing & Quality Control Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Manufacturing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Manufacturing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Manufacturing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Packaging & Labeling Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Packaging & Labeling Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Packaging & Labeling Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Peptide Synthesis Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Peptide Synthesis Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Peptide Synthesis Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Process Development & Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Process Development & Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Process Development & Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 20. Global GMP Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global GMP Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global GMP Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Non-GMP Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Non-GMP Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Non-GMP Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 27. Global Liquid Phase Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Liquid Phase Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Liquid Phase Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Solid Phase Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Solid Phase Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Solid Phase Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 34. Global Biochemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Biochemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Biochemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Immunology Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Immunology Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Immunology Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Molecular Biology Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Molecular Biology Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Molecular Biology Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 47. Global Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Biotechnology Firms Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Biotechnology Firms Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Biotechnology Firms Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Research and Development (R&D) Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Research and Development (R&D) Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Research and Development (R&D) Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Peptide API CDMO Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Peptide API CDMO Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. North America Peptide API CDMO Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. North America Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 71. North America Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 72. North America Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 73. North America Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. North America Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 75. Latin America Peptide API CDMO Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Latin America Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 77. Latin America Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 78. Latin America Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 79. Latin America Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Latin America Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. Europe Peptide API CDMO Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Europe Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 83. Europe Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 84. Europe Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 85. Europe Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 86. Europe Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. Middle East Peptide API CDMO Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Middle East Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 89. Middle East Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 90. Middle East Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 91. Middle East Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Middle East Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Africa Peptide API CDMO Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Africa Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 95. Africa Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 96. Africa Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 97. Africa Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Africa Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Global Peptide API CDMO Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. ASEAN Peptide API CDMO Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. ASEAN Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 102. ASEAN Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 103. ASEAN Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 104. ASEAN Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. ASEAN Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. GCC Peptide API CDMO Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. GCC Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 108. GCC Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 109. GCC Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 110. GCC Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. GCC Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 112. European Union Peptide API CDMO Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. European Union Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 114. European Union Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 115. European Union Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 116. European Union Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. European Union Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. BRICS Peptide API CDMO Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. BRICS Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 120. BRICS Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 121. BRICS Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 122. BRICS Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 123. BRICS Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. G7 Peptide API CDMO Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. G7 Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 126. G7 Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 127. G7 Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 128. G7 Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 129. G7 Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. NATO Peptide API CDMO Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. NATO Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 132. NATO Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 133. NATO Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 134. NATO Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. NATO Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. Global Peptide API CDMO Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. United States Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 138. United States Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 139. United States Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 140. United States Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 141. United States Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. United States Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. Canada Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 144. Canada Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 145. Canada Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 146. Canada Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 147. Canada Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. Canada Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. Mexico Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 150. Mexico Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 151. Mexico Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 152. Mexico Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 153. Mexico Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. Mexico Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Brazil Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 156. Brazil Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 157. Brazil Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 158. Brazil Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 159. Brazil Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. Brazil Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. United Kingdom Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 162. United Kingdom Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 163. United Kingdom Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 164. United Kingdom Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 165. United Kingdom Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. United Kingdom Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Germany Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 168. Germany Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 169. Germany Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 170. Germany Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 171. Germany Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Germany Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. France Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 174. France Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 175. France Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 176. France Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 177. France Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. France Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Russia Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 180. Russia Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 181. Russia Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 182. Russia Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 183. Russia Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. Russia Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. Italy Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 186. Italy Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 187. Italy Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 188. Italy Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 189. Italy Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Italy Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. Spain Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 192. Spain Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 193. Spain Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 194. Spain Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 195. Spain Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. Spain Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 197. China Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 198. China Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 199. China Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 200. China Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 201. China Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. China Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. India Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 204. India Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 205. India Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 206. India Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 207. India Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. India Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Japan Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 210. Japan Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 211. Japan Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 212. Japan Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 213. Japan Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Japan Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. Australia Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 216. Australia Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 217. Australia Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 218. Australia Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 219. Australia Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Australia Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. South Korea Peptide API CDMO Services Market Size, 2017-2032 (USD Million)
TABLE 222. South Korea Peptide API CDMO Services Market Size, by Type, 2017-2032 (USD Million)
TABLE 223. South Korea Peptide API CDMO Services Market Size, by Category, 2017-2032 (USD Million)
TABLE 224. South Korea Peptide API CDMO Services Market Size, by Manufacturing Process, 2017-2032 (USD Million)
TABLE 225. South Korea Peptide API CDMO Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. South Korea Peptide API CDMO Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Global Peptide API CDMO Services Market Share, by Key Player, 2025
TABLE 228. Global Peptide API CDMO Services Market, Key Experts

Companies Mentioned

  • Advanced Peptide Technologies Ltd.
  • Almac Group
  • AmbioPharm Inc.
  • Asymchem Inc.
  • Axplora Group GmbH
  • Bachem Holding AG
  • Cambrex Corporation
  • Corden Pharma International GmbH
  • CordenPharma GmbH
  • CPC Scientific Inc.
  • EUROAPI UK Ltd
  • Evonik Industries AG
  • Genscript Biotech Corporation
  • Lonza Group AG
  • Merck KGaA
  • Neuland Laboratories Ltd.
  • PCI Pharma Services
  • Piramal Pharma Limited
  • Polypeptide Group
  • Siegfried Holding AG
  • Syngene International Ltd.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

Related Topics

Related Reports

Peptide and Oligonucleotide CDMO Market Report 2026 - Product Image

Peptide and Oligonucleotide CDMO Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Oligonucleotide CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Oligonucleotide CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 150 Pages
  • Global
From
Peptide and Oligonucleotide CDMO Market Outlook 2026-2034: Market Share, and Growth Analysis by Product (Peptide CDMO, Oligonucleotide CDMO, Peptide-Oligonucleotide Conjugate CDMO), Application, Service Type, End User - Product Image

Peptide and Oligonucleotide CDMO Market Outlook 2026-2034: Market Share, and Growth Analysis by Product (Peptide CDMO, Oligonucleotide CDMO, Peptide-Oligonucleotide Conjugate CDMO), Application, Service Type, End User

  • Report
  • 160 Pages
  • Global
From
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Report 2026 - Product Image

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) for Formulations Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Active Pharmaceutical Ingredients CDMO Market (API-CDMO) - Global Forecast 2026-2032 - Product Image

Active Pharmaceutical Ingredients CDMO Market (API-CDMO) - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.